Alex P Hunyor Selected Research

Retinaldehyde (Retinal)

1/2021	Prepapillary vascular loop-a new classification.
2/2020	SURGICAL MANAGEMENT OF TRAUMATIC MACULAR HOLE: Optical Coherence Tomography Features and Outcomes.
11/2018	The Visual Outcomes of Macular Hole Surgery: A Registry-Based Study by the Australian and New Zealand Society of Retinal Specialists.
1/2018	Outcomes of Eyes with Failed Primary Surgery for Idiopathic Macular Hole.
1/2018	TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
12/2016	Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration.
9/2015	Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
6/2015	Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration.
5/2015	Novel optical coherence tomography classification of torpedo maculopathy.
3/2015	Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex P Hunyor Research Topics

Disease

16	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 08/2013
7	Endophthalmitis (Ophthalmia) 11/2022 - 06/2012
7	Blindness (Hysterical Blindness) 01/2018 - 03/2014
6	Retinal Detachment (Retinal Detachments) 11/2018 - 09/2007
5	Retinal Perforations 02/2020 - 01/2016
4	Cataract (Cataracts) 01/2019 - 09/2007
2	Choroidal Neovascularization 01/2019 - 03/2015
2	Macular Edema 04/2014 - 09/2007
1	Amaurosis Fugax 01/2021
1	Retinal Artery Occlusion 01/2021
1	Atrophy 01/2020
1	Geographic Atrophy 01/2019
1	Edema (Dropsy) 01/2018
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2018
1	Inflammation (Inflammations) 07/2017
1	Hypersensitivity (Allergy) 01/2017
1	Hemorrhage 03/2015
1	Streptococcal Infections (Streptococcal Infection) 01/2015
1	Epiretinal Membrane (Epiretinal Membranes) 04/2014
1	Proliferative Vitreoretinopathy 07/2013
1	Fallopian Tube Diseases 12/2011
1	Panuveitis 12/2010
1	Retinitis 12/2010
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Breast Neoplasms (Breast Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 01/2021 - 03/2014
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 08/2013
7	Ranibizumab (Lucentis)FDA Link 01/2020 - 03/2014
4	afliberceptIBA 01/2020 - 12/2016
2	Endothelial Growth FactorsIBA 11/2022 - 03/2015
2	Complement Factor H (Factor H)IBA 12/2018 - 07/2017
2	GasesIBA 11/2018 - 01/2016
2	Sulfur HexafluorideIBA 01/2018 - 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 07/2017
1	IodineIBA 01/2017
1	formycin diphosphate (FDP)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2014
1	perfluorooctaneIBA 07/2013
1	Foscarnet FDA LinkGeneric 12/2010

Therapy/Procedure

11	Vitrectomy 02/2020 - 01/2006
6	Intravitreal Injections 11/2022 - 06/2012
5	Therapeutics 01/2018 - 03/2014
4	Injections 11/2022 - 08/2013
2	Scleral Buckling 07/2014 - 07/2013
1	Trabeculectomy (Trabeculoplasty) 01/2019
1	Antibiotic Prophylaxis 08/2018
1	Reoperation 01/2018
1	Traction 04/2014
1	Lasers (Laser) 04/2014
1	Glaucoma Drainage Implants 12/2011